The board of directors of Yonghe Medical Group Co., Ltd. provided earnings guidance based on a preliminary assessment of the Group's unaudited consolidated management accounts for the year ended 31 December 2023 and the information currently available to the Board, the Group expects to record a revenue of approximately RMB 1,765.0 million to RMB 1,780.0 million for the Year, representing an increase of approximately 24.9% to 26.0% over the revenue for the year ended 31 December 2022. Also, the Group expects to incur a loss of not more than RMB 550.0 million for the Year, as compared with a loss of RMB 85.9 million for the year ended December 31, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.16 HKD | 0.00% | -1.69% | -54.15% |
Mar. 28 | Yonghe Medical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 11 | Yonghe Medical to Widen Loss in 2023 | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-54.15% | 74.41M | |
-12.40% | 1.41B |
- Stock Market
- Equities
- 2279 Stock
- News Yonghe Medical Group Co., Ltd.
- Yonghe Medical Group Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2023